scholarly journals Clinical-diagnostic criteria and peculiarities of treatment of urocystitis in cats

2019 ◽  
Vol 10 (1) ◽  
pp. 26-31 ◽  
Author(s):  
N. M. Shulzhenko ◽  
О. М. Chernenko ◽  
O. V. Holubyev ◽  
О. G. Bordunova ◽  
N. I. Suslova
Keyword(s):  
Urinary Tract ◽  
Clinical Laboratory ◽  
Inflammatory Diseases ◽  
Bacterial Colonization ◽  
Abdominal Cavity ◽  
Prostate Gland ◽  
Urine Ph ◽  
Clinical Diagnostic Criteria ◽  
Plant Basis ◽  
Lower Urinary

The results of a study of cats with signs of urocystitis are presented. The general principles of diagnostics based on clinical, laboratory and additional research methods are established. Clinically acute urocystitis was manifested by disorders of urination – pollakiuria, dysuria, stranguria. Some of the animals showed an increase in body temperature, pain in the bladder and tightness of the walls of the abdominal cavity. According to the results of urine study, it was observed that 43.7% of the cats with urocystitis showed an increase in relative density of the urine, a change in urine pH towards higher alkaline levels, urine residue – erythrocytes, leukocytes and microorganisms were indicated. Impurities of salt and sand were found in 58.4% of the cats. In 31.4% of the cats, urocystitis was a complication of urolithiasis. Early diagnosis, especially differential diagnosis of acute and chronic, secondary urocystitis presents difficulties. Therefore, in cases of suspected inflammatory diseases of the urinary tract, a complex examination using ultrasound of the kidneys, bladder, prostate gland (in males) and the uterus (in females) is recommended.With therapeutic purpose, sick cats (two groups of 8 animals/group) were administered: anti-microbial agent (5% solution of Enrofloxacin), spasmolytic medicinal agent – Riabal®. Animals of the second group were additionally administered the drug Cystocure (Candioli Farmaceutici). According to the instructions, the plant basis of the powder Cystocure is presented by extracts of cranberries and orange peels. These substances provide the main properties of the drug – help in resisting the bacterial colonization of the lower urinary tract and change in urine pH to the acid side. The applied therapy positively influenced the clinical condition of the cats. Their general health was improved, painful sensations during the act of urination disappeared, the quantity and frequency of diuresis normalized. On the seventh day of treatment, according to the results of the study, the urine became transparent, no microorganisms were detected. In cats of the second group, which additionally used the drug Cystocure, the amount of salts and sand decreased significantly, the pH of the urine did not exceed the recommended value of 6.4, in contrast to animals of the first group.

Possibilities of phytotherapy in patients with lower urinary tract symptoms due to benign prostate enlargement

2020 ◽  
Vol 10 (4) ◽  
pp. 317-323
Author(s):  
Adel S. Al-Shukri ◽  
Stanislav V. Kostyukov
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Prostate Gland ◽  
Urine Volume ◽  
Good Tolerability ◽  
Clinical Indicators ◽  
Urinary Tract Symptoms ◽  
Main Component ◽  
Lower Urinary

The results of the use of the phytopreparation Tadimax in the treatment of 60 men with mild and moderate lower urinary tract symptoms (LUTS) developed as a result of benign enlargement of the prostate gland are presented. The average age of the patients was 66.5 3.8 years. Tadimax was prescribed 2 tablets 3 times a day, in courses of 7 days with 7 day breaks for 3 months (a total of 6 courses). The data obtained indicate high efficacy and good tolerability of treatment. A decrease in the severity of LUTS was noted in 59 (96.6%) patients, which was accompanied by significant changes in objective clinical indicators: a decrease in residual urine volume and an increase in urine flow rate. Tadimax is a combined preparation, which includes extracts of several medicinal plants, and the main component is Crinum latifolium. The therapeutic effect of Tadimax is based on anti-inflammatory, antiproliferative and immunotropic action.

DISORDER OF URODYNAMIC IN CHILDREN WITH INFLAMMATORY DISEASES OF THE UPPER AND LOWER URINARY TRACT

2021 ◽  
pp. 34-37
Author(s):  
I. Shtrafun ◽  
E. S. Alymbaev ◽  
H. R. Ahmedova ◽  
V. G. Shishkina
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract ◽  
Inflammatory Diseases ◽  
Lower Urinary

scholarly journals Ten-Year Experience with Open Prostatectomy in Maiduguri

ISRN Urology ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Ibrahim Ahmed Gadam ◽  
Ali Nuhu ◽  
Suleiman Aliyu
Keyword(s):  
Urinary Tract ◽  
Benign Prostatic Hyperplasia ◽  
Lower Urinary Tract ◽  
Clinical Laboratory ◽  
Urinary Tract Obstruction ◽  
Prostatic Hyperplasia ◽  
Open Prostatectomy ◽  
Elderly Male ◽  
Lower Urinary Tract Obstruction ◽  
Lower Urinary

Background. Benign prostatic hyperplasia is the most common cause of lower urinary tract obstruction in the elderly male. Aim. To evaluate the effectiveness, safety, and outcome of open prostatectomy in a Nigerian teaching hospital. Material and Methods. Two hundred and fifty-three men with lower urinary tract obstruction clinically due to benign prostatic hyperplasia (BPH) underwent open prostatectomy over a ten-year period (January 2001–December 2010). Data on patients including age, clinical, laboratory, and histology were reviewed and analyzed to determine treatment outcome. Results. A total of 253 patients were studied. Their mean age was 69.11 ± 10.9 years (range 50–98). The most common symptoms at presentation included frequency 229 (90.5%) and poor stream 225 (88.9%). The most common complications at presentation were stones in 41 (16.2%) and bleeding in 37 (14.6%). The most common comorbid conditions were hypertension and diabetes found in 72 (28.5%) and 23 (9.1%), respectively. Transvesical prostatectomy was done for most of the patients, 126 (49.8%). Clot retention and wound infection were the commonest postoperative complications accounting for 19 (7.5%) each. Transient incontinence occurred in 17 (6.7%) patients. There was 1 (0.4%) mortality. Conclusion. Open prostatectomy still has a prime place in the operative treatment of BPH with acceptable postoperative morbidity and very low mortality in the developing world with no facilities for TURP.

scholarly journals Spectrum of Bacterial Colonization Associated with Urothelial Cells from Patients with Chronic Lower Urinary Tract Symptoms

2013 ◽  
Vol 51 (7) ◽  
pp. 2054-2062 ◽  
Author(s):  
R. Khasriya ◽  
S. Sathiananthamoorthy ◽  
S. Ismail ◽  
M. Kelsey ◽  
M. Wilson ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract Symptoms ◽  
Lower Urinary Tract ◽  
Bacterial Colonization ◽  
Urothelial Cells ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

scholarly journals APPLICATION OF “PROXELAN” SUPPOSITORY IN TREATMENT OF SYMPTOMS OF LOWER URINARY WAYS ASSOCIATED WITH CHRONIC PROSTATITE AND BENIGN HYPERPLASIA OF THE PROSTATE GLAND

2018 ◽  
pp. 46-51
Author(s):  
Юрий Заседа
Keyword(s):  
Urinary Tract ◽  
Treatment Regimen ◽  
Lower Urinary Tract ◽  
Prostate Gland ◽  
Study Groups ◽  
Health Clinic ◽  
Treatment Groups ◽  
High Prevalence ◽  
Rectal Suppositories ◽  
Lower Urinary

Relevance. Symptoms of the lower urinary tract take a central role in outpatient urology, primarily due to the high prevalence in the general population.Objective: To analyze the eff ectiveness of suppositories “Proxelan” in the treatment of symptoms of the lower urinary tract associated with chronic prostatitis and benign prostatic hyperplasia of the mild degree.Design. The study was conducted in a prospective design on a contingent of 100 male patients who underwent outpatient treatment at the “Men’s Health Clinic” LLC. Patients were divided into 2 groups, depending on the presence in the treatment regimen of rectal suppositories “Proxelan”.Results of the study. The fi ndings on the diff erences in the intensity of symptom manifestations in the structure of lower urinary tract symptoms, according to the I-PSS scale, indicate that there is a signifi cant clinical eff ect on the symptoms in general for both treatment groups. Diff erences between the eff ect in the study groups range from moderate to minor.Conclusions. It has been established that the inclusion in the treatment regimen of rectal suppositories “Proxelan” allows to increase the clinical eff ect with respect to some indicators, namely: frequent urination and weakening of the urine stream. In addition, signifi cantly improve the quality of life of patients with symptoms of the lower urinary tract.

Prostatic Artery Embolization (PAE) As Treatment for Lower Urinary Tract Obstruction Due To Benign Prostatic Hyperplasia: An Update of the Literature

2019 ◽  
Vol 1 (1) ◽  
pp. 24-53
Author(s):  
Anthony Kodzo-Grey Venyo
Keyword(s):  
Urinary Tract ◽  
Guide Wire ◽  
Prostate Gland ◽  
Artery Embolization ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Prostatic Artery ◽  
Lower Urinary

Prostate artery embolization (PAE) as treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH) was first undertaken in 2000 and since then utilization of PAE for the treatment of symptomatic BPH associated with failure of medical therapy or patients not being fit to undergo general anaesthesia or spinal anaesthesia for surgical treatment of the prostate gland has continued to be undertaken by well trained interventional radiologists in various well equipped interventional radiology units globally especially in the developed countries. PAE is a technically demanding procedure which is only undertaken by well trained interventional radiologists. PAE is undertaken under radiology imaging control via the left or right femoral artery or the radial artery under local anaesthesia. Super-selective catheterization of the small prostatic artery is undertaken with the use of fine microcatheters that traverse the pelvic arteries / internal pudendal arteries. The PAE procedure does involve introduction of microparticles to completely block the prostate arteries. The embolization agents include polyvinyl alcohol (PVA) and other synthetic materials including microspheres. Successful PAE does lead to necrosis and shrinkage of the prostate gland. With regard to the technical details of PAE, the interventional radiologist does obtain access into the arterial system by piercing the femoral artery or the radial artery under radiology imaging control including ultrasound scan with utilization of a trocar which is hollow. A guide-wire is threaded through the trocar and trocar is then removed. A cannula is passed over the guide-wire and once the cannula is in place the guide-wire is removed. The cannula does allow a sheath to be inserted into the artery. Contrast material is injected through the sheath under radiology imaging / fluoroscopic control which does allow the anatomy of the pelvic blood vessels to be illustrated including the anatomy of the internal pudendal artery as well as if the anatomy is normal or there is a variation in the anatomy of the pelvic vessels including whether or not there is tortuosity of the pelvic vessels or atherosclerosis of the vessels. The contrast angiography is utilized to guide the interventional radiologist to identify the prostate artery in order to advance the catheter to the ostium of the prostatic artery and this then enables the radiologist to inject polyvinyl alcohol or microspheres into the prostatic artery. The anatomy of the pelvic vessels does vary which is well known by all interventional radiologists. Successful PAE does refer to complete bilateral embolization of the prostatic arteries but at times the radiologist is only able to undertake unilateral embolization of a prostatic artery due to a variant anatomy of the pelvic vessel or tortuosity of the vessel or atherosclerosis. Over the past 18 years various case reports, case series, and studies of PAE either alone or in comparison with trans-urethral resection of the prostate have been reported in various journals. These publications have mostly shown that PAE is safe and efficacious in improving upon the IPSS, QoL, Q-max, Post -void residual urine volume, as well as reduction in the volume of the prostate. Some of the studies have shown almost equivalent in the IPSS improvement in comparison with the IPSS improvement pursuant to TURP. Nevertheless, some of the reported improvements in other functional outcomes have not been as good as that obtained following TURP. Additionally the studies had been reported with short and medium term-follow-up only hence generally one cannot confidently state what the overall long-term outcome of PAE would be. Nevertheless, PAE has be associated with minor complications mainly and not with major complications including major bleeding. TURP tends to be associated with higher incidence of retrograde ejaculation and erectile dysfunction in comparison with PAE in which the sexual function tends to remain stable. PAE tends to be associated with retention of urine / long period of urethral catheterization in comparison with TURP. The overall cost of PAE tends to be much cheaper in comparison with TURP because of the fact that PAE tends to be undertaken as an outpatient procedure without any hospitalization cost. Specific complications which could occur include non-target embolization that could lead to transient rectitis, or penile ulcer, urinary tract infection, and dysuria. PAE may be associated with pelvic and urethral pain of more than 1 to 3 days but PAE is not associated with dilutional hyponatraemia which occasionally occurs following TURP. There is need for more studies to be undertaken on PAE and to be reported with long-term follow-up to enable a consensus opinion to be made about the long term outcome of PAE. Meanwhile PAE could be undertaken on individuals who have failed medical therapy who are not fit to undergo surgery or who do not want to undergo surgery.   

scholarly journals Analysis of lower urinary tract disease of dogs

2017 ◽  
Vol 37 (11) ◽  
pp. 1275-1280 ◽  
Author(s):  
Claudia Iveth Mendóza-López ◽  
Javier Del-Angel-Caraza ◽  
Israel Alejandro Quijano-Hernández ◽  
Marco Antonio Barbosa-Mireles
Keyword(s):  
Risk Factors ◽  
Urinary Tract ◽  
Lower Urinary Tract ◽  
Clinical Laboratory ◽  
Imaging Studies ◽  
German Shepherd ◽  
Micturition Disorders ◽  
Tract Disease ◽  
Tract Infections ◽  
Lower Urinary

ABSTRACT: Lower urinary tract diseases (LUTD) include different conditions that affect the urinary bladder, urethra and prostate. The objective of this study was to determine the frequency of different related diseases, to characterize the population affected, and to determine risk factors in dogs. The clinical cases were diagnosed with LUTD through physical examination, and clinical laboratory and imaging studies. Male dogs had a greater predisposition to present a LUTD. Dogs from 3 months to 18 years with a median of 8 years were affected, and the most affected breeds were Poodle, Labrador, German shepherd, Schnauzer, Cocker Spaniel and Chihuahua. The LUTD presented with the following frequencies: bacterial urinary tract infection 34.02%; micturition disorders 22.68%; urolithiasis 20.61%; prostatic disease 14.43%; traumatic problems 8.24%. Sixty-seven per cent of the cases were specific diseases, such as uncomplicated and complicated bacterial urinary tract infections, urinary retention of neurologic origin and silica urolithiasis.

Use of Morgan Repertory in UTI: A Case Series

2019 ◽  
Vol 32 (04) ◽  
pp. 235-250
Author(s):  
Ruchira Sharma ◽  
Abhishek Kumar Sharma ◽  
Shishir Mathur
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Lower Urinary Tract ◽  
Prostate Gland ◽  
Case Series ◽  
Bladder Capacity ◽  
Clinical Problem ◽  
Lower Urinary Tract Infection ◽  
Lower Urinary

Abstract Background Patients with lower urinary tract infection report with unknown aetiology as a frequently encountered clinical problem. Aims To treat the patients suffering from acute symptoms of lower urinary tract infection as an add-on to standard urological care. Materials and Methods After exclusion of morphologic abnormalities, all patients with acute lower urinary tract infection who filled urinary tract infection questionnaire were offered additional homoeopathic care as an add-on to standard urological care. Standard urological care included in this study were to have adequate fluid intake to ensure the passage of 1.5 to 2 L of urine per day and maintain hygiene, especially in case of women. Symptoms were fever, incontinence, increased spasticity, decreased bladder capacity or pain, or decreased general health combined with significant bacteriuria. Seven patients were enrolled who fulfilled all the above inclusion criteria. The potencies were used according to disease grading and patient susceptibility. Descriptive statistics was used for analysis and repertory of the urinary organs and prostate gland including condylomata compiled by A.R. Morgan used for homoeopathic medicine selection. Result Seven patients were followed up for a period of 2 years. Six patients were free of urinary tract infection (UTI), whereas UTI symptoms were reduced in one patient. Conclusion Our initial experience with curing of UTI with homoeopathy according to repertory of the urinary organs and prostate gland including condylomata compiled by A.R. Morgan as add on to standard urologic care was encouraging. For an evidence-based evaluation of this concept, prospective studies are required.

scholarly journals Diagnostics of anatomical obstruction of the lower urinary tract using uroflowmetry with a pharmacourodynamic test

Urology ◽  
2021 ◽  
Vol 25 (2) ◽  
Author(s):  
E.A. Kvyatkovsky ◽  
T.O. Kvyatkovska ◽  
E.V. Pilin
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract ◽  
Urinary Tract Obstruction ◽  
Prostate Gland ◽  
Volumetric Flow Rate ◽  
Urethral Obstruction ◽  
Non Invasive ◽  
Lower Urinary Tract Obstruction ◽  
Invasive Method ◽  
Lower Urinary

Uroflowmetry is an effective, non-invasive method for detecting lower urinary tract obstruction. However, by the nature of the uroflowgram, it is impossible to distinguish between the anatomical and functional obstruction of the urethra. The aim of the study was to develop a screening non-invasive method for the diagnosis of anatomical urethral obstruction using uroflowmetry with a pharmacourodynamic test with selective alpha-1-blocker silodosin. The study involved 235 patients aged 66.2±1.8 years (from 30 to 76 years) with symptoms of the lower urinary tract (LUTS). Uroflowmetry was performed using a “Flow-K” uroflowmeter. Ultrasound examinations of the kidneys, prostate and bladder with determination of residual urine were performed using a HONDA HS-2000 ultrasound machine. All patients underwent a pharmacourodynamic test: repeated uroflowmetry 2.5-3 hours after a single dose of 8 mg of silodosin, taking into account the pharmacodynamics of the drug. During the pharmacourodynamic test, 15 patients with obstructive or obstructive-interrupted uroflowgram had no reaction to silodosin, which was considered a positive test for anatomical (mechanical) urethral obstruction. Аn increase the maximum and average volumetric flow rate of urine during urination by 25-30%, respectively from 9.02±0.24 ml/s up to 11.69±0.32 ml/s and from 5.64±0.21 ml/s to 7.03±0.25 ml/s, were noted in 220 patients with obstructive, obstructive-interrupted obstructive-intermittent or intermittent type of uroflowgram when conducting a pharmacaurodynamic test. Such results were considered negative for anatomical (mechanical) urethral obstruction. They testified to functional obstruction of the urethra, which was subsequently successfully corrected with prescribing selective alpha-1-blockers. Patients with a positive pharmacourodynamic test were prescribed further examination using such methods as ureteroscopy, urethrocystoscopy, retrograde urethrography, to confirm the violation of the patency of the urethra or bladder neck. Urethral stricture was diagnosed in 10 patients, a calculus of the posterior urethra in 2 patients, a median lobe of the prostate gland in 3 patients with BPH. In the presence of obstructive or obstructive-interrupted uroflowgram in patients with LUTS, the pharmacourodynamic test with silodosin can be used as a screening non-invasive test to detect anatomical obstruction of the lower urinary tract.

Treatment of beneficial prostate hyperplasia of large sizes: traditional surgical, low-invasive and laser technologies (literature review)

2021 ◽  
Vol 24 (4) ◽  
pp. 62-68
Author(s):  
G. E. Roitberg ◽  
V. V. Astashov ◽  
K. G. Mkrtchyan ◽  
A. A. Lomshakov
Keyword(s):  
Urinary Tract ◽  
Surgical Treatment ◽  
Benign Prostatic Hyperplasia ◽  
Lower Urinary Tract ◽  
Clinical Symptoms ◽  
Prostate Gland ◽  
Prostatic Hyperplasia ◽  
Prostate Hyperplasia ◽  
Surgical Tactics ◽  
Lower Urinary

Benign prostatic hyperplasia – one of the most common diseases in older men. The treatment strategy for benign prostatic hyperplasia consists in its drug therapy, or active surgical tactics. The indication for planned surgical treatment of benign prostatic hyperplasia is the progression of symptoms of the lower urinary tract, which are not amenable to drug correction. Men with a large prostate volume of more than 80 m3, with severe symptoms of the lower urinary tract, with a history of acute urinary retention episodes, represent a difficult group of patients in terms of choosing the tactics of surgical treatment. This article discusses the most common operations that are used in the treatment of benign prostatic hyperplasia (especially of large sizes): open adenectomy, transurethral resection of the prostate gland, enucleation of benign prostatic hyperplasia using a holmium laser, embolization of an artery of the prostate gland. Surgical treatment of benign prostatic hyperplasia requires an individual approach to the patient, taking into account his age, concomitant pathology and clinical symptoms.

Sign in / Sign up

Export Citation Format

Share Document